AbCellera Biologics abcellera.com


Public list: Digital Health (6540) Pharma Startups (6570)

AbCellera Biologics (NASDAQ: ABCL) provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of monoclonal antibody therapies. Its single-cell platform integrates end-to-end capabilities for therapeutic antibody discovery through a combination of technologies including proprietary immunizations, microfluidics, high-throughput imaging, genomics, computation, and laboratory automation.

AbCellera Biologics (NASDAQ: ABCL) provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of monoclonal antibody therapies. Its single-cell platform integrates end-to-end capabilities for therape...Show all

Company (IPO / Went public)

Phone: 604-559-9005

Fax:

2215 Yukon Street

Vancouver, V5Y 0A1
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AbCellera Biologics $247.1M Dec 11, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AbCellera Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)